Upstream Bio Inc (NAS:UPB)
$ 6.99 -0.22 (-3.04%) Market Cap: 380.40 Mil Enterprise Value: 86.93 Mil PE Ratio: 0 PB Ratio: 1.25 GF Score: 10/100

Upstream Bio Inc at Goldman Sachs Healthcare Conference Transcript

Jun 10, 2026 / 02:40 PM GMT
Release Date Price: $6.28 (-6.13%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

UPB.OQ - Upstream Bio Inc
Upstream Bio Inc at Goldman Sachs Healthcare Conference
Jun 10, 2026 / 02:40PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and thank you for joining us today. My name is Elizabeth Webster and I'm on the biotech equity research team here at Goldman Sachs.

And today with us, we have Ran Sutherland, the CEO of Upstream Bio. And Ran, to start, can you introduce Upstream, your lead assets, and how you see the company position today and where you're most focused as we head into the second-half of the year?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Sure, I'd be happy to. And Elizabeth, thank you for having us. It's a real privilege to be able to share the Upstream Bio
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot